Shenxiang Suhe pill improves cardiac function through modulating gut microbiota and serum metabolites in rats after acute myocardial infarction

References

• Aa LX, Fei F, Qi Q, Sun RB, Gu SH, Di ZZ, Aa JY, Wang GJ, Liu CX. 2020. Rebalancing of the gut flora and microbial metabolism is responsible for the anti-arthritis effect of kaempferol. Acta Pharmacol Sin. 41(1):73–81. doi: 10.1038/s41401-019-0279-8.
   PubMed Web of Science ®Google Scholar
• Badavi M, Sadeghi N, Dianat M, Samarbafzadeh A. 2014. Effects of gallic acid and cyclosporine a on antioxidant capacity and cardiac markers of rat isolated heart after ischemia/reperfusion. Iran Red Crescent Med J. 16(6):e16424. doi: 10.5812/ircmj.16424.
   PubMed Web of Science ®Google Scholar
• Chen D, Liu J, Chen H, Guan Y, Zhu Q, Su D. 2000. Effect of Shenxiang Suhe pill on rats with myocardial ischemia. Tradi Chinese Drug Res Clin Pharmacol. 11:86–88. (in Chinese)
   Google Scholar
• Chen S, Huang Y, Su H, Zhu W, Wei Y, Long Y, Shi Y, Wei J. 2022. The integrated analysis of transcriptomics and metabolomics unveils the therapeutical effect of asiatic acid on alcoholic hepatitis in rats. Inflammation. 45(4):1780–1799. doi: 10.1007/s10753-022-01660-x.
   PubMed Web of Science ®Google Scholar
• Chen Y, Liu Y, Wang Y, Chen X, Wang C, Chen X, Yuan X, Liu L, Yang J, Zhou X. 2022. Prevotellaceae produces butyrate to alleviate PD-1/PD-L1 inhibitor-related cardiotoxicity via PPARα-CYP4X1 axis in colonic macrophages. J Exp Clin Cancer Res. 41(1):1. doi: 10.1186/s13046-021-02201-4.
   PubMed Web of Science ®Google Scholar
• Chinese Pharmacopoeia Commission. 2020. Pharmacopoeia of the People’s Republic of China. Vol 1. Beijing (China): Ministry of Health of the People’s Republic of China; p. 1424.
   Google Scholar
• Chorell E, Olsson T, Jansson JH, Wennberg P. 2020. Lysophospholipids as predictive markers of ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI). Metabolites. 11(1):25. doi: 10.3390/metabo11010025.
   PubMed Web of Science ®Google Scholar
• de Vries MR, Ewing MM, de Jong RCM, MacArthur MR, Karper JC, Peters EAB, Nordzell M, Karabina SAP, Sexton D, Dahlbom I, et al. 2021. Identification of IgG1 isotype phosphorylcholine antibodies for the treatment of inflammatory cardiovascular diseases. J Intern Med. 290(1):141–156. doi: 10.1111/joim.13234.
   PubMed Web of Science ®Google Scholar
• Feng W, Jin L, Xie Q, Huang L, Jiang Z, Ji Y, Li C, Yang L, Wang D. 2018. Eugenol protects the transplanted heart against ischemia/reperfusion injury in rats by inhibiting the inflammatory response and apoptosis. Exp Ther Med. 16(4):3464–3470. doi: 10.3892/etm.2018.6598.
   PubMed Web of Science ®Google Scholar
• Forte E, Perkins B, Sintou A, Kalkat HS, Papanikolaou A, Jenkins C, Alsubaie M, Chowdhury RA, Duffy TM, Skelly DA, et al. 2021. Cross-priming dendritic cells exacerbate immunopathology after ischemic tissue damage in the heart. Circulation. 143(8):821–836. doi: 10.1161/CIRCULATIONAHA.120.044581.
   PubMed Web of Science ®Google Scholar
• Gao F, Lv YW, Long J, Chen JM, He JM, Ruan XZ, Zhu HB. 2019. Butyrate improves the metabolic disorder and gut microbiome dysbiosis in mice induced by a high-fat diet. Front Pharmacol. 10:1040. doi: 10.3389/fphar.2019.01040.
   PubMed Web of Science ®Google Scholar
• Gao Y, Hao J, Zhang H, Qian G, Jiang R, Hu J, Wang J, Lei Z, Zhao G. 2015. Protective effect of the combinations of glycyrrhizic, ferulic and cinnamic acid pretreatment on myocardial ischemia-reperfusion injury in rats. Exp Ther Med. 9(2):435–445. doi: 10.3892/etm.2014.2134.
   PubMed Web of Science ®Google Scholar
• Gelfand EV, Cannon CP. 2007. Myocardial infarction: contemporary management strategies. J Intern Med. 262(1):59–77. doi: 10.1111/j.1365-2796.2007.01790.x.
   PubMed Web of Science ®Google Scholar
• Gong P, Li Y, Yao C, Guo H, Hwang H, Liu X, Xu Y, Wang X. 2017. Traditional Chinese medicine on the treatment of coronary heart disease in recent 20 years. J Altern Complement Med. 23(9):659–666. doi: 10.1089/acm.2016.0420.
   PubMed Web of Science ®Google Scholar
• Han S, Van Treuren W, Fischer CR, Merrill BD, DeFelice BC, Sanchez JM, Higginbottom SK, Guthrie L, Fall LA, Dodd D, et al. 2021. A metabolomics pipeline for the mechanistic interrogation of the gut microbiome. Nature. 595(7867):415–420. doi: 10.1038/s41586-021-03707-9.
   PubMed Web of Science ®Google Scholar
• Huang J, Wei S, Jiang C, Xiao Z, Liu J, Peng W, Zhang B, Li W. 2022. Involvement of abnormal gut microbiota composition and function in doxorubicin-induced cardiotoxicity. Front Cell Infect Microbiol. 12:808837. doi: 10.3389/fcimb.2022.808837.
   PubMed Web of Science ®Google Scholar
• Huang JP, Cheng ML, Wang CH, Shiao MS, Chen JK, Hung LM. 2016. High-fructose and high-fat feeding correspondingly lead to the development of lysoPC-associated apoptotic cardiomyopathy and adrenergic signaling-related cardiac hypertrophy. Int J Cardiol. 215:65–76. doi: 10.1016/j.ijcard.2016.03.239.
   PubMed Web of Science ®Google Scholar
• Huang P, Wang L, Li Q, Tian X, Xu J, Xu J, Xiong Y, Chen G, Qian H, Jin C, et al. 2020. Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19. Cardiovasc Res. 116(2):353–367. doi: 10.1093/cvr/cvz139.
   PubMed Web of Science ®Google Scholar
• Kongpichitchoke T, Chiu MT, Huang TC, Hsu JL. 2016. Gallic acid content in Taiwanese teas at different degrees of fermentation and its antioxidant activity by inhibiting PKCδ activation: in vitro and in silico studies. Molecules. 21(10):1346. doi: 10.3390/molecules21101346.
   PubMed Web of Science ®Google Scholar
• Kwun JS, Kang SH, Lee HJ, Park HK, Lee WJ, Yoon CH, Suh JW, Cho YS, Youn TJ, Chae IH. 2020. Comparison of thrombus, gut, and oral microbiomes in Korean patients with ST-elevation myocardial infarction: a case-control study. Exp Mol Med. 52(12):2069–2079. doi: 10.1038/s12276-020-00543-1.
   PubMed Web of Science ®Google Scholar
• Liu H, Chen X, Hu X, Niu H, Tian R, Wang H, Pang H, Jiang L, Qiu B, Chen X, et al. 2019. Alterations in the gut microbiome and metabolism with coronary artery disease severity. Microbiome. 7(1):68. doi: 10.1186/s40168-019-0683-9.
   PubMed Web of Science ®Google Scholar
• Liu J, Wang S, Tan W, Lv B, Dai Y, Wang Y, Zhang Z, Wang X. 2020. Dual-screening of anti-inflammatory and antioxidant active ingredients of Shenxiang Suhe pill and its potential multi-target therapy for coronary heart disease. Biomed Pharmacother. 129:110283. doi: 10.1016/j.biopha.2020.110283.
   PubMed Web of Science ®Google Scholar
• Nabel EG, Braunwald E. 2012. A tale of coronary artery disease and myocardial infarction. N Engl J Med. 366(1):54–63. doi: 10.1056/NEJMra1112570.
   PubMed Web of Science ®Google Scholar
• Oestvang J, Anthonsen MW, Johansen B. 2011. lysoPC and PAF trigger arachidonic acid release by divergent signaling mechanisms in monocytes. J Lipids. 2011:532145. doi: 10.1155/2011/532145.
   PubMedGoogle Scholar
• Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, Zeiher A, Chaitman BR, Leslie S, Stern T. 2001. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA. 285(13):1711–1718. doi: 10.1001/jama.285.13.1711.
   PubMed Web of Science ®Google Scholar
• Serena C, Ceperuelo-Mallafré V, Keiran N, Queipo-Ortuño MI, Bernal R, Gomez-Huelgas R, Urpi-Sarda M, Sabater M, Pérez-Brocal V, Andrés-Lacueva C, et al. 2018. Elevated circulating levels of succinate in human obesity are linked to specific gut microbiota. ISME J. 12(7):1642–1657. doi: 10.1038/s41396-018-0068-2.
   PubMed Web of Science ®Google Scholar
• Shi T, Li D, Long S. 2022. Clinical observation of Shenxiang Suhe pills combined with aspirin in the treatment of type 2 diabetes mellitus complicated with coronary heart disease. China Pharmaceuticals. 31:87–90. (in Chinese)
   Google Scholar
• Song T, Guan X, Wang X, Qu S, Zhang S, Hui W, Men L, Chen X. 2021. Dynamic modulation of gut microbiota improves post-myocardial infarct tissue repair in rats via butyric acid-mediated histone deacetylase inhibition. FASEB J. 35(3):e21385. doi: 10.1096/fj.201903129RRR.
   PubMed Web of Science ®Google Scholar
• Songvut P, Chariyavilaskul P, Khemawoot P, Tansawat R. 2021. Pharmacokinetics and metabolomics investigation of an orally modified formula of standardized Centella asiatica extract in healthy volunteers. Sci Rep. 11(1):12568. doi: 10.1038/s41598-021-92113-2.
   PubMed Web of Science ®Google Scholar
• Stone GW. 2008. Angioplasty strategies in ST-segment-elevation myocardial infarction: part II: intervention after fibrinolytic therapy, integrated treatment recommendations, and future directions. Circulation. 118(5):552–566. doi: 10.1161/CIRCULATIONAHA.107.739243.
   PubMed Web of Science ®Google Scholar
• Tang WH, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, Wu Y, Hazen SL. 2013. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 368(17):1575–1584. doi: 10.1056/NEJMoa1109400.
   PubMed Web of Science ®Google Scholar
• Toya T, Corban MT, Marrietta E, Horwath IE, Lerman LO, Murray JA, Lerman A. 2020. Coronary artery disease is associated with an altered gut microbiome composition. PLoS One. 15(1):e0227147. doi: 10.1371/journal.pone.0227147.
   PubMed Web of Science ®Google Scholar
• Wang C, Niimi M, Watanabe T, Wang Y, Liang J, Fan J. 2018. Treatment of atherosclerosis by traditional Chinese medicine: questions and quandaries. Atherosclerosis. 277:136–144. doi: 10.1016/j.atherosclerosis.2018.08.039.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wu J, Zhu J, Ding C, Xu W, Hao H, Zhang J, Wang G, Cao L. 2021. Ginsenosides regulation of lysophosphatidylcholine profiles underlies the mechanism of Shengmai Yin in attenuating atherosclerosis. J Ethnopharmacol. 277:114223. doi: 10.1016/j.jep.2021.114223.
   PubMed Web of Science ®Google Scholar
• Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, Feldstein AE, Britt EB, Fu X, Chung YM, et al. 2011. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 472(7341):57–63. doi: 10.1038/nature09922.
   PubMed Web of Science ®Google Scholar
• Wei X, Xie T, Zhong X, Zhao X, Wang X. 2022. Effect of Shenxiang Suhe pills on intestinal flora in rats with myocardial infarction. J Tianjin Univ Trad Chinese Med. 41:76–84. (in Chinese)
   Google Scholar
• Wu X, Cao J, Li M, Yao P, Li H, Xu W, Yuan C, Liu J, Wang S, Li P, et al. 2020. An integrated microbiome and metabolomic analysis identifies ­immunoenhancing features of Ganoderma lucidum spores oil in mice. Pharmacol Res. 158:104937. doi: 10.1016/j.phrs.2020.104937.
   PubMed Web of Science ®Google Scholar
• Yang Y, Zhang H, Yan B, Zhang T, Gao Y, Shi Y, Le G. 2017. Health effects of dietary oxidized tyrosine and dityrosine administration in mice with nutrimetabolomic strategies. J Agric Food Chem. 65(32):6957–6971. doi: 10.1021/acs.jafc.7b02003.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Liu H, Yu B, Tao H, Li J, Wu Z, Liu G, Yuan C, Guo L, Cui B. 2020. Lycium barbarum polysaccharide attenuates myocardial injury in high-fat diet-fed mice through manipulating the gut microbiome and fecal metabolome. Food Res Int. 138(Pt B):109778. doi: 10.1016/j.foodres.2020.109778.
   PubMedGoogle Scholar
• Zhao X, Fu Z, Yao M, Cao Y, Zhu T, Mao R, Huang M, Pang Y, Meng X, Li L, et al. 2021. Mulberry (Morus alba L.) leaf polysaccharide ameliorates insulin resistance‐ and adipose deposition‐associated gut microbiota and lipid metabolites in high‐fat diet‐induced obese mice. Food Sci Nutr. 10(2):617–630. doi: 10.1002/fsn3.2689.
   PubMed Web of Science ®Google Scholar
• Zheng Z, Lyu W, Ren Y, Li X, Zhao S, Yang H, Xiao Y. 2021. Allobaculum involves in the modulation of intestinal ANGPTLT4 expression in mice treated by high-fat diet. Front Nutr. 8:690138. doi: 10.3389/fnut.2021.690138.
   PubMed Web of Science ®Google Scholar
• Zhou X, Li J, Guo J, Geng B, Ji W, Zhao Q, Li J, Liu X, Liu J, Guo Z, et al. 2018. Gut-dependent microbial translocation induces inflammation and cardiovascular events after ST-elevation myocardial infarction. Microbiome. 6(1):66. doi: 10.1186/s40168-018-0441-4.
   PubMedGoogle Scholar
• Zhu X, Liu H, Yu H, Guo S, Lao Q, Li C. 2016. Experimental study on therapeutic effects of Shenxiang Suhe Pill on cardiovascular diseases. J Zhejiang Sci-Tech Univ (Natural Sciences Edition). 35:630–635. (in Chinese)
   Google Scholar
• Zhuang R, Meng Q, Ma X, Shi S, Gong S, Liu J, Li M, Gu W, Li D, Zhang X, et al. 2022. CD4(+)FoxP3(+)CD73(+) regulatory T cell promotes cardiac healing post-myocardial infarction. Theranostics. 12(6):2707–2721. doi: 10.7150/thno.68437.
   PubMed Web of Science ®Google Scholar
• Zijlstra F. 2000. Long-term benefit of primary angioplasty compared to thrombolytic therapy for acute myocardial infarction. Eur Heart J. 21(18):1487–1489. doi: 10.1053/euhj.2000.2192.
   PubMed Web of Science ®Google Scholar
• Zununi Vahed S, Barzegari A, Zuluaga M, Letourneur D, Pavon-Djavid G. 2018. Myocardial infarction and gut microbiota: an incidental connection. Pharmacol Res. 129:308–317. doi: 10.1016/j.phrs.2017.11.008.
   PubMed Web of Science ®Google Scholar